EmCyte
Manufacturing · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4331 Veronica S Shoemaker Blvd Ste 4, Fo...Phone Number
(239) 481-7725Website
www.emcyte.comRevenue
$5.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About EmCyte
EmCyte Corporation®, headquartered in Fort Myers, Florida, is the world leader in platelet rich plasma and progenitor stem cell biologics. Its PURE regenerative product solutions have set a new standard in regenerative deliverables with protocol versatility and outstanding recovery performance. EmCyte products are manufactured in its 30,000 square foot manufacturing facility equipped with certified clean rooms and state-of-the-art manufacturing equipment. With over 20 years of experience, EmCyte's commitment to innovation has made a clinical difference in countries around the globe, and its team of qualified experts are available to provide advanced training and clinical support.Explore more
EmCyte Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is EmCyte your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once EmCyte has new funding data
Check out if EmCyte is spiking on competitors!
Earning: See what the market has to say on EmCyte recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at EmCyte
EmCyte, which may be a good buyer, showed buying intent in Masked Content Topic
Check if EmCyte has recently received funding, and reach out quickly before it becomes old news!
Click to see if EmCyte had a recent Job posting/layoffs
Product Launch: Get notified when EmCyte launches new products
Recommended Actions
Find VP level buyers at EmCyte
Find 3 more new buyers
Compare Similar Companies to EmCyte
Compare insights from companies similar to EmCyte, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
EmCyte is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
EmCyte is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about EmCyte.
EmCyte financials insights
Gather financial insights about EmCyte, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
EmCyte Tech Stack
A closer look at the technologies used by EmCyte
See more technologies
EmCyte News & Media
EmCyte Announces the Acquisition of the Centrepid Platelet Concentrator
FORT MYERS, Fla., Feb. 20, 2020 /PRNewswire/ -- EmCyte, the world leader in platelet rich plasma and progenitor stem cell biologics, announces the acquisition of all of the assets of Cellmedix Holdings LLC, including the Centrepid Platelet Concentrator system. This acquisition bolsters...EmCyte Announces FDA 510(k) Clearance for its Progenikine® Concentrating System for Adipose
EmCyte, the world leader in platelet rich plasma and progenitor stem cell biologics, announces its FDA 510(k) clearance for its Progenikine® Concentrating System for adipose lipoplasty. The system's 510(k) is cleared for all medical procedures involving the harvesting and transferring of autologous adipose tissue. The system's 510(k) number is K191564.EmCyte Announces FDA 510(k) Clearance for its Progenikine® Concentrating System for Adipose
FORT MYERS, Fla., Dec. 3, 2019 /PRNewswire/ -- EmCyte, the world leader in platelet rich plasma and progenitor stem cell biologics, announces its FDA 510(k) clearance for its Progenikine® Concentrating System for adipose lipoplasty. The system's 510(k) is cleared for all medical...Worldwide Business with kathy ireland®: See EmCyte Corporation Introduce Their New Standard in Regenerative Medicine
Worldwide Business with kathy ireland® is pleased to announce an exclusive interview with EmCyte Corporation CEO Patrick Pennie to discuss their devices used for autologous regenerative biologics. (PRWeb October 17, 2019) Read the full story at https://www.prweb.com/releases/worldwide_business_with_kathy_ireland_see_emcyte_corporation_introduce_their_new_standard_in_regenerative_medicine/prweb16656562.htm
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding EmCyte
Sign Up For FreeTo access detailed company insights
EmCyte Corporation®, headquartered in Fort Myers, Florida, is the world leader in platelet rich plasma and progenitor stem cell biologics. Its PURE regenerative product solutions have set a new standard in regenerative deliverables with protocol versatility and outstanding recovery performance. EmCyte products are manufactured in its 30,000 square... Read More
